IRADIMED CORPORATION Statistics
Total Valuation
IRMD has a market cap or net worth of $792.22 million. The enterprise value is $724.54 million.
| Market Cap | 792.22M |
| Enterprise Value | 724.54M |
Important Dates
The next confirmed earnings date is Thursday, February 13, 2025, before market open.
| Earnings Date | Feb 13, 2025 |
| Ex-Dividend Date | Nov 15, 2024 |
Share Statistics
IRMD has 12.67 million shares outstanding. The number of shares has increased by 0.48% in one year.
| Current Share Class | 12.67M |
| Shares Outstanding | 12.67M |
| Shares Change (YoY) | +0.48% |
| Shares Change (QoQ) | +0.16% |
| Owned by Insiders (%) | 37.05% |
| Owned by Institutions (%) | 47.63% |
| Float | 7.07M |
Valuation Ratios
The trailing PE ratio is 42.58 and the forward PE ratio is 38.97.
| PE Ratio | 42.58 |
| Forward PE | 38.97 |
| PS Ratio | 10.87 |
| Forward PS | 9.65 |
| PB Ratio | 9.30 |
| P/TBV Ratio | 9.63 |
| P/FCF Ratio | 43.59 |
| P/OCF Ratio | 32.95 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 32.71, with an EV/FCF ratio of 40.70.
| EV / Earnings | 38.90 |
| EV / Sales | 10.16 |
| EV / EBITDA | 32.71 |
| EV / EBIT | 33.98 |
| EV / FCF | 40.70 |
Financial Position
The company has a current ratio of 9.21, with a Debt / Equity ratio of 0.00.
| Current Ratio | 9.21 |
| Quick Ratio | 7.70 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | 0.01 |
| Debt / FCF | 0.01 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 23.58% and return on invested capital (ROIC) is 16.62%.
| Return on Equity (ROE) | 23.58% |
| Return on Assets (ROA) | 14.67% |
| Return on Invested Capital (ROIC) | 16.62% |
| Return on Capital Employed (ROCE) | 24.74% |
| Revenue Per Employee | $481,791 |
| Profits Per Employee | $125,858 |
| Employee Count | 148 |
| Asset Turnover | 0.79 |
| Inventory Turnover | 1.42 |
Taxes
In the past 12 months, IRMD has paid $4.99 million in taxes.
| Income Tax | 4.99M |
| Effective Tax Rate | 21.11% |
Stock Price Statistics
The stock price has increased by +39.92% in the last 52 weeks. The beta is 0.83, so IRMD's price volatility has been lower than the market average.
| Beta (5Y) | 0.83 |
| 52-Week Price Change | +39.92% |
| 50-Day Moving Average | 56.20 |
| 200-Day Moving Average | 48.85 |
| Relative Strength Index (RSI) | 68.53 |
| Average Volume (20 Days) | 37,660 |
Short Selling Information
The latest short interest is 148,736, so 1.17% of the outstanding shares have been sold short.
| Short Interest | 148,736 |
| Short Previous Month | 124,046 |
| Short % of Shares Out | 1.17% |
| Short % of Float | 2.10% |
| Short Ratio (days to cover) | 3.51 |
Income Statement
In the last 12 months, IRMD had revenue of $71.31 million and earned $18.63 million in profits. Earnings per share was $1.46.
| Revenue | 71.31M |
| Gross Profit | 55.00M |
| Operating Income | 21.32M |
| Pretax Income | 23.60M |
| Net Income | 18.63M |
| EBITDA | 22.15M |
| EBIT | 21.32M |
| Earnings Per Share (EPS) | $1.46 |
Balance Sheet
The company has $51.72 million in cash and $264,075 in debt, giving a net cash position of $51.46 million or $4.06 per share.
| Cash & Cash Equivalents | 51.72M |
| Total Debt | 264,075 |
| Net Cash | 51.46M |
| Net Cash Per Share | $4.06 |
| Equity (Book Value) | 83.43M |
| Book Value Per Share | 6.59 |
| Working Capital | 66.22M |
Cash Flow
In the last 12 months, operating cash flow was $23.55 million and capital expenditures -$5.75 million, giving a free cash flow of $17.80 million.
| Operating Cash Flow | 23.55M |
| Capital Expenditures | -5.75M |
| Free Cash Flow | 17.80M |
| FCF Per Share | $1.40 |
Margins
Gross margin is 77.14%, with operating and profit margins of 29.91% and 26.12%.
| Gross Margin | 77.14% |
| Operating Margin | 29.91% |
| Pretax Margin | 33.12% |
| Profit Margin | 26.12% |
| EBITDA Margin | 31.07% |
| EBIT Margin | 29.91% |
| FCF Margin | 24.97% |
Dividends & Yields
This stock pays an annual dividend of $0.60, which amounts to a dividend yield of 0.96%.
| Dividend Per Share | $0.60 |
| Dividend Yield | 0.96% |
| Dividend Growth (YoY) | -73.21% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 41.10% |
| Buyback Yield | -0.48% |
| Shareholder Yield | 0.50% |
| Earnings Yield | 2.40% |
| FCF Yield | 2.29% |
Analyst Forecast
The average price target for IRMD is $60.00, which is -4.02% lower than the current price. The consensus rating is "Strong Buy".
| Price Target | $60.00 |
| Price Target Difference | -4.02% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
IRMD has an Altman Z-Score of 33.81 and a Piotroski F-Score of 7.
| Altman Z-Score | 33.81 |
| Piotroski F-Score | 7 |